794557385	794557385	CD	B-NP	O
|	|	NN	I-NP	O
TRCH	TRCH	NN	I-NP	O
|	|	NN	I-NP	O
96592521	96592521	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
425637	425637	CD	B-NP	O
|	|	CC	I-NP	O
6/29/1999	6/29/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
DEHYDRATION	DEHYDRATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/11/1999	1/11/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/28/1999	2/28/1999	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ISCHEMIC	ISCHEMIC	NNP	B-NP	O
HEPATOCELLULAR	HEPATOCELLULAR	NNP	I-NP	O
INJURY	INJURY	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ALCOHOL	ALCOHOL	NNP	B-NP	O
ABUSE	ABUSE	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ALCOHOLIC	ALCOHOLIC	NN	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Vomiting	Vomiting	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
chills	chill	NNS	B-NP	O
for	for	IN	B-PP	O
18	18	CD	B-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
51	51	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
African-American	African-American	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
long-standing	long-standing	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
alcoholic	alcoholic	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
T2	T2	NN	I-NP	O
,	,	,	O	O
N1	N1	NN	B-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
resection	resection	NN	B-NP	O
and	and	CC	I-NP	O
XRT	XRT	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
vomiting	vomit	VBG	B-VP	O
x	x	SYM	B-NP	O
18	18	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
with	with	IN	B-PP	O
congestion	congestion	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cough	cough	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADJP	O
productive	productive	JJ	I-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
later	later	RB	B-ADVP	O
which	which	WDT	B-NP	O
turned	turn	VBD	B-VP	O
dark	dark	JJ	B-ADJP	O
in	in	IN	B-PP	O
color	color	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
blood	blood	NN	I-NP	O
tinged	tinge	VBD	B-VP	O
sputum	sputum	NN	B-NP	O
or	or	CC	O	O
rust	rust	VB	B-VP	O
colored	color	VBN	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
progressed	progress	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
weak	weak	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
awoke	awoke	NN	I-NP	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
coughing	coughing	NN	I-NP	O
fit	fit	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
vomited	vomit	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
hematemesis	hematemesis	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
repeatedly	repeatedly	RB	B-ADVP	O
had	have	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
vomiting	vomit	VBG	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
28	28	CD	I-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
drink	drink	VB	I-VP	O
liquids	liquid	NNS	B-NP	O
without	without	IN	B-PP	O
vomiting	vomit	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
took	take	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
eight	eight	CD	I-NP	O
to	to	TO	I-NP	O
ten	ten	CD	I-NP	O
Tylenol	Tylenol	NN	I-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
tablets	tablet	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
became	become	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
light-headed	light-headed	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
dizzy	dizzy	JJ	I-ADJP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
with	with	IN	B-PP	O
standing	stand	VBG	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
subjective	subjective	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
nonbloody	nonbloody	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
loose	loose	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
employee	employee	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Hos	Hos	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
cafeteria	cafeteria	NN	I-NP	O
,	,	,	O	O
went	go	VBD	B-VP	O
to	to	TO	I-VP	O
visit	visit	VB	I-VP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
urged	urge	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
triaged	triage	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergent	emergent	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EW	EW	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
77/50	77/50	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
138	138	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
side	side	NN	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Notable	Notable	JJ	B-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
and	and	CC	O	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Squamous	Squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
noted	note	VBN	B-VP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
excision	excision	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
with	with	IN	B-PP	O
XRT	XRT	NN	B-NP	B-protein
and	and	CC	O	O
hyperbaric	hyperbaric	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
dental	dental	JJ	I-NP	O
extractions	extraction	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
flap	flap	NN	I-NP	O
revision	revision	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
in	in	IN	B-PP	O
1985	1985	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
lysis	lysis	NN	I-NP	O
of	of	IN	B-PP	O
adhesions	adhesion	NNS	B-NP	O
,	,	,	O	O
getting	get	VBG	B-VP	O
an	an	DT	B-NP	O
exploratory	exploratory	JJ	I-NP	O
laparotomy	laparotomy	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
1997	1997	CD	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
One	One	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
cigarettes	cigarette	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
and	and	CC	O	O
one-half	one-half	NN	B-NP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
pint	pint	NN	I-NP	O
of	of	IN	B-PP	O
brandy	brandy	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
``	``	``	O	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O
''	''	''	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
orthopnea	orthopnea	JJ	I-NP	O
,	,	,	I-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

As	As	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
knows	know	VBZ	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
well-appearing	well-appearing	JJ	I-ADJP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
98.0	98.0	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
110/84	110/84	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
was	be	VBD	B-VP	O
101	101	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
16	16	CD	B-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
;	;	:	O	O
extraocular	extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
;	;	:	O	O
sclera	sclera	NN	B-NP	O
were	be	VBD	B-VP	O
muddy	muddy	JJ	B-ADJP	O
without	without	IN	B-PP	O
icterus	icterus	NN	B-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
postsurgical	postsurgical	JJ	B-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
meningismus	meningismus	NN	I-NP	O
and	and	CC	O	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
5	5	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
auscultated	auscultate	VBN	B-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
nondisplaced	nondisplaced	JJ	I-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
intensity	intensity	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
was	be	VBD	B-VP	O
nonpalpable	nonpalpable	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
spleen	spleen	NN	I-NP	O
tip	tip	NN	I-NP	O
palpable	palpable	JJ	I-NP	O
and	and	CC	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
perfuse	perfuse	NN	B-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x	x	NN	B-NP	O
3	3	CD	I-NP	O
with	with	IN	B-PP	O
intact	intact	JJ	B-NP	O
cranial	cranial	JJ	I-NP	O
nerve	nerve	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
strength	strength	NN	I-NP	O
and	and	CC	I-NP	O
sensation	sensation	NN	I-NP	O
were	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
5/5	5/5	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
toes	toe	NNS	I-NP	O
were	be	VBD	B-VP	O
down-going	down-goe	VBG	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
reflexes	reflex	NNS	I-NP	O
were	be	VBD	B-VP	O
symmetric	symmetric	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

DATA	DATA	NN	B-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
values	value	NNS	I-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
electrolytes	electrolyte	NNS	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Magnesium	Magnesium	NNP	B-NP	O
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
6.5	6.5	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
48	48	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
200	200	CD	B-NP	O
.	.	.	O	O

Differential	Differential	JJ	B-ADJP	O
:	:	:	O	O
78	78	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
band	band	NN	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
lymphs	lymph	NNS	I-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
monos	mono	NNS	I-NP	O
.	.	.	O	O

MCV	MCV	NN	B-NP	O
was	be	VBD	B-VP	O
104	104	CD	B-NP	O
.	.	.	O	O

RDW	RDW	NN	B-NP	B-protein
was	be	VBD	B-VP	O
14	14	CD	B-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
140	140	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
605	605	CD	I-NP	I-DNA
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
119	119	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
was	be	VBD	B-VP	O
2.6	2.6	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

Lipase	Lipase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
319	319	CD	B-NP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
44	44	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INRs	INR	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
prothrombin	prothrombin	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
19.9	19.9	CD	B-NP	O
Troponin	Troponin	NN	I-NP	O
was	be	VBD	B-VP	O
0.22	0.22	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
or	or	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
117	117	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Q-wave	Q-wave	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
and	and	CC	O	O
Q-wave	Q-wave	NN	B-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
and	and	CC	I-NP	O
V3	V3	NN	I-NP	B-protein
.	.	.	O	O

Q-wave	Q-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
V3	V3	NN	B-NP	O
and	and	CC	I-NP	O
V6	V6	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
keto	keto	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
leukocyte	leukocyte	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
,	,	,	O	O
28	28	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
whites	white	NNS	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
squamous	squamous	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
acutely	acutely	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
sepsis	sepsis	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
results	result	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
IV	IV	CD	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
T-wave	T-wave	JJ	I-NP	O
inversions	inversion	NNS	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
previously	previously	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
indeterminate	indeterminate	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
medicine	medicine	NN	B-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
summarized	summarize	VBN	I-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
include	include	VBP	B-VP	O
cigarette	cigarette	NN	B-NP	O
smoking	smoking	NN	I-NP	O
and	and	CC	O	O
postmenopausal	postmenopausal	JJ	B-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
51	51	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
known	known	JJ	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
known	known	JJ	I-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
drink	drink	VB	B-VP	O
heavily	heavily	RB	B-ADVP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
so	so	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
years	year	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
cardiotoxic	cardiotoxic	JJ	I-NP	O
effect	effect	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
T-wave	T-wave	JJ	I-NP	O
inversions	inversion	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
indeterminate	indeterminate	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
protocol	protocol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	O
CKs	CK	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
below	below	IN	B-PP	O
50	50	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
persisted	persist	VBD	B-VP	O
despite	despite	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
dilated	dilate	VBN	I-VP	O
left	left	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
of	of	IN	B-PP	O
5.6	5.6	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
inferoseptal	inferoseptal	JJ	B-NP	O
and	and	CC	I-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
apical	apical	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
consultation	consultation	NN	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
evaluation	evaluation	VB	I-VP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
new	new	JJ	I-NP	O
depressed	depressed	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
and	and	CC	O	O
focal	focal	JJ	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
clinically	clinically	RB	B-ADJP	O
silent	silent	JJ	I-ADJP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
and	and	CC	O	O
Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	B-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
this	this	DT	B-NP	O
antihypotensive	antihypotensive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
despite	despite	IN	B-PP	O
efforts	effort	NNS	B-NP	O
to	to	TO	B-VP	O
scale	scale	VB	I-VP	O
it	it	PRP	B-NP	O
back	back	RB	B-ADVP	O
in	in	IN	B-PP	O
dosages	dosage	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
medicines	medicine	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
slowed	slow	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
burning	burn	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
alleved	alleve	VBN	I-VP	O
with	with	IN	B-PP	O
Maalox	Maalox	NNP	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
catheterization	catheterization	NN	I-NP	I-protein
lab	lab	NN	I-NP	I-protein
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
The	The	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
ventricular	ventricular	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
36/10	36/10	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
35/13	35/13	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
16	16	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
6.13	6.13	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
3.69	3.69	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
noted	note	VBD	B-VP	O
normal	normal	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
left	left	JJ	I-NP	O
ventriculogram	ventriculogram	NN	I-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
preserved	preserve	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Garret	Garret	NNP	I-NP	O
Dalrymple	Dalrymple	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
consultation	consultation	NN	I-NP	O
service	service	NN	I-NP	O
followed	follow	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
reversal	reversal	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
alcoholic	alcoholic	JJ	B-NP	O
cardiotoxicity	cardiotoxicity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
for	for	IN	B-PP	O
primary	primary	JJ	B-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
other	other	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
heparinized	heparinize	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
apical	apical	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
transaminases	transaminase	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
transaminases	transaminase	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
10	10	CD	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
transaminases	transaminase	NNS	I-NP	B-protein
might	might	MD	B-VP	O
reflect	reflect	VB	I-VP	O
alcoholic	alcoholic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
alcohol	alcohol	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
drink	drink	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
drinks	drink	VBZ	B-VP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
pint	pint	NN	I-NP	O
of	of	IN	B-PP	O
brandy	brandy	NN	B-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
transaminases	transaminase	NNS	I-NP	B-protein
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
Tylenol	Tylenol	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
superimposed	superimpose	VBN	B-VP	O
upon	upon	IN	B-PP	O
hepatocellular	hepatocellular	JJ	B-NP	O
damage	damage	NN	I-NP	O
from	from	IN	B-PP	O
alcoholic	alcoholic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
entertained	entertain	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
naphthyl	naphthyl	NN	B-NP	O
cystine	cystine	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
that	that	DT	B-NP	O
medication	medication	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
upon	upon	IN	B-PP	O
GI	GI	NN	B-NP	O
consultation	consultation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
transaminases	transaminase	NNS	I-NP	B-protein
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
4000	4000	CD	I-NP	O
AST	AST	NN	I-NP	O
and	and	CC	O	O
1000	1000	CD	B-NP	O
ALT	ALT	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hepatitic	hepatitic	JJ	I-NP	O
serologies	serology	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
positive	positive	JJ	B-NP	B-protein
hepatitis	hepatitis	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
core	core	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
serologies	serology	NNS	I-NP	O
including	include	VBG	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
and	and	CC	I-NP	O
hepatitis	hepatitis	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
surface	surface	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
GI	GI	NN	I-NP	O
service	service	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
hepatocellular	hepatocellular	JJ	I-NP	O
injury	injury	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
attributable	attributable	JJ	I-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
``	``	``	I-NP	O
shock	shock	NN	I-NP	O
liver	liver	NN	I-NP	O
''	''	''	I-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
dilatation	dilatation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
cm	cm	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
sludging	sludging	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
isolated	isolate	VBN	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
AST	AST	NN	B-NP	O
and	and	CC	I-NP	O
ALT	ALT	NN	I-NP	O
and	and	CC	I-NP	O
bilirubin	bilirubin	NN	I-NP	O
without	without	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
hepatotoxicity	hepatotoxicity	NN	I-NP	O
was	be	VBD	B-VP	O
entertained	entertain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ALT	ALT	NN	I-NP	O
had	have	VBD	B-VP	O
fallen	fall	VBN	I-VP	O
to	to	TO	B-PP	O
221	221	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
AST	AST	NN	I-NP	O
had	have	VBD	B-VP	O
fallen	fall	VBN	I-VP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
total	total	JJ	I-NP	O
bilirubin	bilirubin	NN	I-NP	O
had	have	VBD	B-VP	O
fallen	fall	VBN	I-VP	O
to	to	TO	B-PP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
from	from	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
perspective	perspective	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
encephalopathy	encephalopathy	NN	B-NP	O
or	or	CC	I-NP	O
asterixis	asterixis	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
ammonia	ammonia	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
45	45	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
indicative	indicative	JJ	B-ADJP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
eventually	eventually	RB	B-ADVP	O
indicated	indicate	VBD	B-VP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
Enterococcus	Enterococcus	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
clear	clear	JJ	B-ADJP	O
symptomatically	symptomatically	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
vulvar	vulvar	JJ	I-NP	O
area	area	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
topical	topical	JJ	B-NP	B-protein
Nystatin	Nystatin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
clinically	clinically	RB	B-ADVP	O
cleared	clear	VBD	B-VP	O
her	her	PRP$	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

FVN	FVN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
hypomagnesemia	hypomagnesemia	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
significant	significant	JJ	B-NP	O
magnesium	magnesium	NN	I-NP	O
repletion	repletion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
hypomagnesemia	hypomagnesemia	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	I-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
magnesium	magnesium	NN	I-NP	O
stores	store	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
clearly	clearly	RB	B-ADVP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hematologic	Hematologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
slightly	slightly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
heparin	heparin	NN	B-NP	O
bolus	bolus	NN	I-NP	O
and	and	CC	O	O
supratherapeutic	supratherapeutic	JJ	B-NP	O
prothrombin	prothrombin	NN	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
had	have	VBD	B-VP	O
normalized	normalize	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
as	as	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
depletion	depletion	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
alcoholism	alcoholism	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
for	for	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
synthetic	synthetic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hypotension	Hypotension	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
initial	initial	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
for	for	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
was	be	VBD	B-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
became	become	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
normally	normally	RB	B-ADVP	O
exists	exist	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
normal	normal	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
80	80	CD	I-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
stressed	stress	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
must	must	MD	B-VP	O
maintain	maintain	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	FW	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP	B-NP	O
circulating	circulate	VBG	B-VP	O
blood	blood	NN	B-NP	O
volume	volume	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
intolerant	intolerant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
antihypotensive	antihypotensive	JJ	I-NP	O
medicines	medicine	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
cardioprotection	cardioprotection	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
random	random	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
was	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
issue	issue	NN	I-NP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	I-VP	O
likely	likely	RB	I-VP	O
excluded	exclude	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
on	on	IN	B-PP	O
endocrine	endocrine	NN	B-NP	O
and	and	CC	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
issues	issue	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Nystatin	Nystatin	NN	B-NP	O
topical	topical	JJ	I-NP	O
cream	cream	NN	I-NP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
q.day	q.day	NN	I-NP	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Elroy	Elroy	NNP	I-NP	O
Forcell	Forcell	NNP	I-NP	O
in	in	IN	B-PP	O
MES	MES	NNP	B-NP	O
GEERT	GEERT	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Aamodt	Aamodt	NNP	I-NP	O
was	be	VBD	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
excellent	excellent	JJ	B-NP	O
continuity	continuity	NN	I-NP	O
of	of	IN	B-PP	O
care	care	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
PORFIRIO	PORFIRIO	NNP	B-NP	O
FUSSNER	FUSSNER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AI86	AI86	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STACEY	STACEY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
ETZLER	ETZLER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OC7	OC7	NNP	I-NP	O
FI364/6532	FI364/6532	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
42383	42383	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

H1GHYV69AG	H1GHYV69AG	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/15/99	11/15/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/16/99	10/16/99	CD	B-NP	O

